Simplex Trading’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$42K Buy
38,019
+23,639
+164% +$26.1K ﹤0.01% 1465
2025
Q1
$11K Buy
+14,380
New +$11K ﹤0.01% 1737
2024
Q4
Sell
-178
Closed 2930
2024
Q3
$0 Sell
178
-1,304
-88% ﹤0.01% 2797
2024
Q2
$4K Sell
1,482
-138
-9% -$372 ﹤0.01% 2004
2024
Q1
$11K Buy
1,620
+171
+12% +$1.16K ﹤0.01% 1833
2023
Q4
$5K Buy
1,449
+1,130
+354% +$3.9K ﹤0.01% 1976
2023
Q3
$0 Sell
319
-9,122
-97% ﹤0.01% 2819
2023
Q2
$44K Sell
9,441
-895
-9% -$4.17K ﹤0.01% 1307
2023
Q1
$58K Buy
10,336
+8,832
+587% +$49.6K ﹤0.01% 1182
2022
Q4
$15K Buy
1,504
+139
+10% +$1.39K ﹤0.01% 1688
2022
Q3
$30K Buy
1,365
+1,192
+689% +$26.2K ﹤0.01% 1601
2022
Q2
$4K Sell
173
-10,244
-98% -$237K ﹤0.01% 2185
2022
Q1
$403K Buy
10,417
+9,991
+2,345% +$387K ﹤0.01% 814
2021
Q4
$24K Buy
+426
New +$24K ﹤0.01% 2120
2021
Q3
Hold
0
3080
2021
Q2
Hold
0
3148
2021
Q1
Hold
0
2868
2020
Q4
Sell
-19,284
Closed -$770K 2646
2020
Q3
$770K Buy
+19,284
New +$770K ﹤0.01% 403
2020
Q2
Hold
0
2344
2020
Q1
Sell
-1,579
Closed -$30K 2369
2019
Q4
$30K Sell
1,579
-8,809
-85% -$167K ﹤0.01% 1380
2019
Q3
$161K Sell
10,388
-342
-3% -$5.3K ﹤0.01% 709
2019
Q2
$217K Sell
10,730
-7,683
-42% -$155K ﹤0.01% 653
2019
Q1
$323K Buy
18,413
+10,019
+119% +$176K ﹤0.01% 532
2018
Q4
$107K Buy
8,394
+8,280
+7,263% +$106K ﹤0.01% 839
2018
Q3
$1K Sell
114
-13,051
-99% -$114K ﹤0.01% 1907
2018
Q2
$149K Sell
13,165
-16,297
-55% -$184K ﹤0.01% 848
2018
Q1
$287K Buy
29,462
+25,468
+638% +$248K 0.01% 536
2017
Q4
$24K Buy
3,994
+3,890
+3,740% +$23.4K ﹤0.01% 1396
2017
Q3
$0 Buy
+104
New ﹤0.01% 2069